Any current/future new fundraising through debt or equity?

The transcript does not mention any current or future plans for fundraising through debt or equity. No specific discussions or indications about raising capital via loans, bonds, or issuing new shares were made during the Q1 FY24 earnings call. The management focused on operational performance, cost-saving measures, site rationalization, and market conditions but did not address fundraising activities. The Company is working on improving profitability internally and awaiting incentives but has not indicated any need for external fundraising at present.

Any current/future capex/capital investment/strategic investment?

Bodal Chemicals is installing a capacity of 63,000 metric tons per annum for benzene derivatives, progressing well with the Saykha Greenfield project expected to start trial runs from Q3 FY24. The company is working on upgrading technology and diversifying from core dye stuff and dye intermediate businesses to specialty chemical products like benzene derivatives. Once the new business site stabilizes with decent demand visibility, the company plans to restart its Sulphuric Acid project. Internally, Bodal is considering closing or stopping production at some manufacturing sites with high overhe

Future growth expectations in sales/revenue/volumes?

Demand is currently subdued, with slow performance in key sectors like textile, leather, and paper. Industry expects weakness to continue in the short term, with a gradual recovery anticipated from the second half of FY24. Dye intermediates prices (e.g., H-Acid and Vinyl Sulphone) are low, but a level playing field with China is established, reducing dumping concerns. Production volumes for dye stuffs have increased quarter-on-quarter, but sales volumes remain affected by subdued demand. Chlor-Alkali business expects meaningful contribution in coming years due to technology upgradation and hea

Future growth expectations in earnings/operating earnings/profits/EPS?

Company expects the tough demand environment to last 1-2 years but anticipates automatic demand recovery thereafter. Gradual improvement expected from second half of FY24, particularly in Q3 and Q4. Internal cost-saving initiatives underway, including potential closure of less profitable manufacturing sites to reduce overheads by up to Rs. 2 crore per month. Eligible for Punjab government incentives (~Rs. 18-20 crore per annum), expected to positively impact income in upcoming quarters. Expansion into benzene derivatives progressing, with trial run expected from Q3 FY24, diversifying revenue s

Current/ Expected Orderbook/ Pending Orders?

The order book for the end-use industry is currently "more or less empty," indicating very low pending orders or backlog. Company expects that once demand revives, especially from developed markets, order inflow will improve quickly. Demand is expected to improve gradually from the second half of the current year (FY24) onwards. Internal efforts are ongoing to optimize production and reduce overheads while external demand remains subdued. Overall, the Company expects a positive shift in orders and demand as market conditions improve post the current downturn.

IN US

Sale is live|00:00:00left today

Bodal Chemicals LtdQ2 FY23Chemicals & Petrochemicals

Bodal Chemicals Ltd Q2 FY23 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹66.3P/E: 30.4Market Cap: ₹921 CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 4

Margin

Category 2

Fundraise

N/A

Order

Capex

Yes

1 of 4 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 4

→Demand is currently subdued, with slow performance in key sectors like textile, leather, and paper.
→Industry expects weakness to continue in the short term, with a gradual recovery anticipated from the second half of FY24.
→Dye intermediates prices (e.g., H-Acid and Vinyl Sulphone) are low, but a level playing field with China is established, reducing dumping concerns.
→Production volumes for dye stuffs have increased quarter-on-quarter, but sales volumes remain affected by subdued demand.
→Chlor-Alkali business expects meaningful contribution in coming years due to technology upgradation and healthy demand from FMCG, textile, and paper industries.
→New benzene derivatives capacity (63,000 MT) expected to start trial runs by Q3 FY24, aiding diversification and growth.
→Internal measures such as plant optimization and overhead cost reduction will improve profitability.
→Overall, growth momentum in India is strong, and the Company is optimistic about demand recovery from the second half of the year.

Margin guidance

Category 2

→Company expects the tough demand environment to last 1-2 years but anticipates automatic demand recovery thereafter.
→Gradual improvement expected from second half of FY24, particularly in Q3 and Q4.
→Internal cost-saving initiatives underway, including potential closure of less profitable manufacturing sites to reduce overheads by up to Rs. 2 crore per month.
→Eligible for Punjab government incentives (~Rs. 18-20 crore per annum), expected to positively impact income in upcoming quarters.
→Expansion into benzene derivatives progressing, with trial run expected from Q3 FY24, diversifying revenue streams.
→Chlor-Alkali business expected to contribute meaningfully in coming years due to technology upgrades and healthy demand from FMCG, textile, and paper sectors.
→Overall, modest earnings growth anticipated in medium term, with recovery driven by improved demand, cost optimization, and product diversification.

3 more insights locked — sign up free to unlock

Fundraise plans

→The transcript does not mention any current or future plans for fundraising through debt or equity.
→No specific discussions or indications about raising capital via loans, bonds, or issuing new shares were made during the Q1 FY24 earnings call.
→The management focused on operational performance, cost-saving measures, site rationalization, and market conditions but did not address fundraising activities.
→The Company is working on improving profitability internally and awaiting incentives but has not indicated any need for external fundraising at present.

Order book

→The order book for the end-use industry is currently "more or less empty," indicating very low pending orders or backlog.
→Company expects that once demand revives, especially from developed markets, order inflow will improve quickly.
→Demand is expected to improve gradually from the second half of the current year (FY24) onwards.
→Internal efforts are ongoing to optimize production and reduce overheads while external demand remains subdued.
→Overall, the Company expects a positive shift in orders and demand as market conditions improve post the current downturn.

Capex plans

Yes

→Bodal Chemicals is installing a capacity of 63,000 metric tons per annum for benzene derivatives, progressing well with the Saykha Greenfield project expected to start trial runs from Q3 FY24.
→The company is working on upgrading technology and diversifying from core dye stuff and dye intermediate businesses to specialty chemical products like benzene derivatives.
→Once the new business site stabilizes with decent demand visibility, the company plans to restart its Sulphuric Acid project.
→Internally, Bodal is considering closing or stopping production at some manufacturing sites with high overhead costs and low margins to reduce expenses by up to Rs. 2 crore per month.

How does Bodal Chemicals Ltd rank vs peers in Chemicals & Petrochemicals?

Pro feature

1Bodal Chemicals Ltd

Rev 4Mar 2

See full Chemicals & Petrochemicals sector rankings

Want more stocks like Bodal Chemicals Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio